Want to see HK:0348 full AI Analyst Report?
0348 Stock Chart & Stats
HK$0.14
>-HK$0.01(-2.78%)
At close: 4:00 PM EST
HK$0.14
>-HK$0.01(-2.78%)
Day’s Range― - ―
52-Week RangeHK$0.05 - HK$0.22
Previous CloseN/A
Volume850.00K
Average Volume (3M)735.98K
Market Cap
HK$43.92M
Enterprise ValueHK$154.73M
Total Cash (Recent Filing)HK$62.62M
Total Debt (Recent Filing)HK$106.13M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding770,480,830
10 Day Avg. Volume624,920
30 Day Avg. Volume735,980
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)-2.72
Price to Sales (P/S)1.05
P/FCF Ratio35.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Positive Free Cash FlowSustained positive operating and free cash flow in 2024–2025, though small, shows the business can convert revenue into cash. Durable cash generation provides runway to service obligations, fund restructuring or targeted investments and reduces immediate refinancing pressure compared with purely cash-burning peers.
Improving Gross MarginAn improving gross margin indicates better cost control or pricing power at the core product level. If sustained, stronger gross margins support operating leverage and make it easier to achieve profitability as fixed cost base is optimized, improving long-term earnings durability.
Narrowing Net LossesA sharp reduction in net losses suggests management actions or operational improvements are beginning to take effect. Continued narrowing of losses can slow equity erosion, improve access to capital, and is a prerequisite for restoring balance-sheet health over a multi‑quarter horizon.
Bears Say
Negative Shareholder EquityPersisting negative shareholder equity is a structural red flag that erodes creditor and investor confidence. It distorts leverage metrics, can restrict access to financing, and increases risk of covenant breaches or solvency concerns absent sustained profitability or capital injections.
High Debt Relative To AssetsDebt that is large relative to total assets indicates elevated leverage and limited balance-sheet flexibility. With small free cash flow versus debt, interest and principal servicing could constrain investment and operational choices, increasing restructuring or refinancing risk over the medium term.
Revenue Trending DownOngoing revenue declines reduce scale and undermine operating leverage needed to absorb fixed costs. Persistent top-line erosion makes sustained profitability harder to achieve and magnifies the impact of debt and negative equity on long-term solvency and growth prospects.
China Healthwise Holdings News
0348 FAQ
What was China Healthwise Holdings Ltd.’s price range in the past 12 months?
China Healthwise Holdings Ltd. lowest stock price was HK$0.05 and its highest was HK$0.22 in the past 12 months.
What is China Healthwise Holdings Ltd.’s market cap?
China Healthwise Holdings Ltd.’s market cap is HK$43.92M.
When is China Healthwise Holdings Ltd.’s upcoming earnings report date?
China Healthwise Holdings Ltd.’s upcoming earnings report date is Aug 20, 2026 which is in 19 days.
How were China Healthwise Holdings Ltd.’s earnings last quarter?
China Healthwise Holdings Ltd. released its earnings results on Mar 27, 2026. The company reported -HK$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.005.
Is China Healthwise Holdings Ltd. overvalued?
According to Wall Street analysts China Healthwise Holdings Ltd.’s price is currently Overvalued.
Does China Healthwise Holdings Ltd. pay dividends?
China Healthwise Holdings Ltd. does not currently pay dividends.
What is China Healthwise Holdings Ltd.’s EPS estimate?
China Healthwise Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Healthwise Holdings Ltd. have?
China Healthwise Holdings Ltd. has 770,480,830 shares outstanding.
What happened to China Healthwise Holdings Ltd.’s price movement after its last earnings report?
China Healthwise Holdings Ltd. reported an EPS of -HK$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Healthwise Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0348
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Healthwise Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
101.19%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.59%
Trailing 12-Months
Company Description
China Healthwise Holdings Ltd.
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand. It is also involved in money lending business; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong.
Technical Analysis
New Century Healthcare Holding Co. Ltd.
―
EC Healthcare
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―